BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

454 related articles for article (PubMed ID: 33217958)

  • 1. Cyclooxygenase Inhibition Safety and Efficacy in Inflammation-Based Psychiatric Disorders.
    Perrone MG; Centonze A; Miciaccia M; Ferorelli S; Scilimati A
    Molecules; 2020 Nov; 25(22):. PubMed ID: 33217958
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclooxygenase-2: a therapeutic target.
    Turini ME; DuBois RN
    Annu Rev Med; 2002; 53():35-57. PubMed ID: 11818462
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy, safety and potential clinical roles of the COX-2-specific inhibitors.
    van der Bijl P; van der Bijl P
    Int J Immunopathol Pharmacol; 2003; 16(2 Suppl):17-22. PubMed ID: 14552700
    [TBL] [Abstract][Full Text] [Related]  

  • 4. COX-2: separating myth from reality.
    McKenna F
    Scand J Rheumatol Suppl; 1999; 109():19-29. PubMed ID: 10422543
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Current status of study on selective cyclooxygenase-2 inhibitors and evaluation of its application].
    He W; Liu CF; Huang CQ
    Di Yi Jun Yi Da Xue Xue Bao; 2002 Feb; 22(2):184-6. PubMed ID: 12390825
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyclooxygenase-2 inhibitors: promise or peril?
    Mengle-Gaw LJ; Schwartz BD
    Mediators Inflamm; 2002 Oct; 11(5):275-86. PubMed ID: 12467519
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intelligent use of NSAIDs--where do we stand?
    Berger RG
    Expert Opin Pharmacother; 2001 Jan; 2(1):19-30. PubMed ID: 11336565
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The cardiovascular safety of cyclooxygenase-2 (COX-2) inhibitors].
    Hasdai D; Gottlieb S; Godbourt U; Hod H; Kaluski E
    Harefuah; 2002 Oct; 141(10):922-4. PubMed ID: 12420602
    [No Abstract]   [Full Text] [Related]  

  • 9. Dual acting anti-inflammatory drugs: a reappraisal.
    Bertolini A; Ottani A; Sandrini M
    Pharmacol Res; 2001 Dec; 44(6):437-50. PubMed ID: 11735348
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cyclooxygenase-2 inhibition and side-effects of non-steroidal anti-inflammatory drugs in the gastrointestinal tract.
    Meyer-Kirchrath J; Schrör K
    Curr Med Chem; 2000 Nov; 7(11):1121-9. PubMed ID: 11032962
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of COX-2 in acute pain and the use of selective COX-2 inhibitors for acute pain relief.
    Lee Y; Rodriguez C; Dionne RA
    Curr Pharm Des; 2005; 11(14):1737-55. PubMed ID: 15892672
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison of renal-related adverse drug reactions between rofecoxib and celecoxib, based on the World Health Organization/Uppsala Monitoring Centre safety database.
    Zhao SZ; Reynolds MW; Lejkowith J; Whelton A; Arellano FM
    Clin Ther; 2001 Sep; 23(9):1478-91. PubMed ID: 11589261
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Update on clinical developments with celecoxib, a new specific COX-2 inhibitor: what can we expect?
    Geis GS
    Scand J Rheumatol Suppl; 1999; 109():31-7. PubMed ID: 10422544
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective COX-2 inhibitors and dual acting anti-inflammatory drugs: critical remarks.
    Bertolini A; Ottani A; Sandrini M
    Curr Med Chem; 2002 May; 9(10):1033-43. PubMed ID: 12733982
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Safe use of anti-inflammatory analgesics].
    Finnish Society of Gastroenterology and the Task force of Finnish Rheumatological Society
    Duodecim; 2003; 119(22):2167-71. PubMed ID: 14702803
    [No Abstract]   [Full Text] [Related]  

  • 16. [Cyclooxygenase inhibition].
    Hitzenberger G
    Wien Med Wochenschr; 2003; 153(5-6):94. PubMed ID: 12705060
    [No Abstract]   [Full Text] [Related]  

  • 17. [New non-steroidal anti-rheumatic drugs: selective inhibitors of inducible cyclooxygenase].
    Stichtenoth DO; Zeidler H; Frölich JC
    Med Klin (Munich); 1998 Jul; 93(7):407-15. PubMed ID: 9711054
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gastrointestinal safety of NSAIDs versus COX-2 inhibitors.
    Guslandi M
    Lancet; 2007 Apr; 369(9570):1344-1345. PubMed ID: 17448814
    [No Abstract]   [Full Text] [Related]  

  • 19. [New nonsteroidal anti-inflammatory agents: nitric oxide donors and selective cyclooxygenase-2 inhibitors].
    Bannwarth B; Berenbaum F
    Rev Med Interne; 1999 Aug; 20 Suppl 3():341s-345s. PubMed ID: 10480184
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aspirin, steroidal and non-steroidal anti-inflammatory drugs for the treatment of Alzheimer's disease.
    Jaturapatporn D; Isaac MG; McCleery J; Tabet N
    Cochrane Database Syst Rev; 2012 Feb; (2):CD006378. PubMed ID: 22336816
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.